Therapy Areas: Respiratory
RaySearch Laboratories announces treatment of first patient in the US by Anderson Regional Cancer Centre using combination of RayStation and the TomoTherapy Treatment Delivery System
8 March 2019 -

Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Thursday that Anderson Regional Cancer Centre in Meridian, Mississippi, US, has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation and Accuray Incorporated's TomoTherapy Treatment Delivery System.

Reportedly, this is the first-ever treatment in the US using the two innovative technologies.

This first treatment combining RayStation and TomoTherapy System at Anderson Regional Cancer Centre was successfully administered to treat a prostate cancer patient. Moving forward, the centre plans to use this combination of TPS and radiation treatment delivery system to also treat cancers of the breast, lung and head and neck.

According to the company, Anderson Regional Cancer Centre first began using RayStation in 2013 with its conventional linear accelerators, which provided significant benefits for workflow and patient treatments. The centre then added the TomoTherapy System, a highly advanced radiation treatment. This centre has worked closely with RaySearch and Accuray to join the technologies and is now using RayStation for all radiation treatment planning, which is providing substantial gains in efficiency.

Accuray Incorporated is a radiation oncology company.

RaySearch Laboratories develops software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.

Login
Username:

Password: